Document Detail

Pseudomonas corneoscleritis.
MedLine Citation:
PMID:  3541633     Owner:  NLM     Status:  MEDLINE    
We evaluated three cases of Pseudomonas aeruginosa corneoscleritis, one associated with the use of contaminated eyedrops; another in an elderly, debilitated patient; and the third in a patient who had previously undergone penetrating keratoplasty. In the first two cases, control of the infection was achieved by intensive antibiotic therapy alone. The third case required evisceration of the eye following spontaneous perforation at the site of scleral involvement. Histopathologic findings showed persistence of the organism in the sclera despite intensive antibiotic therapy for six days.
E Alfonso; K R Kenyon; L D Ormerod; R Stevens; M D Wagoner; D M Albert
Related Documents :
21857623 - Elevated cerebrospinal fluid b-2 microglobulin as a tumor marker in a patient with myel...
1002113 - Simultaneous estimation of four plasma androgens before and after dynamic tests in wome...
4041193 - Tularemia: emergency department presentation of an infrequently recognized disease.
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  American journal of ophthalmology     Volume:  103     ISSN:  0002-9394     ISO Abbreviation:  Am. J. Ophthalmol.     Publication Date:  1987 Jan 
Date Detail:
Created Date:  1987-02-06     Completed Date:  1987-02-06     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0370500     Medline TA:  Am J Ophthalmol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  90-8     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Cornea / microbiology
Corneal Transplantation
Drug Contamination
Inflammation / etiology,  therapy
Keratitis / etiology,  therapy*
Ophthalmic Solutions / adverse effects
Postoperative Complications / therapy
Pseudomonas Infections / therapy*
Sclera* / microbiology
Grant Support
Reg. No./Substance:
0/Ophthalmic Solutions

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  S-antigen immunoreactivity in trilateral retinoblastoma.
Next Document:  Occupational therapy in adult day-care (position paper). American Occupational Therapy Association.